Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About - Politics, Policy, Political Views

Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer

SAN FRANCISCO and SUZHOU,China, April 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases,…

Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn't Want You to Know About

(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit. We appreciate your support!) The COVID-19 pandemic, and the ensuing response by the medical establishment, was an eye-opening experience for tens of millions of Americans. We watched as the medical establishment put the biopharmaceutical complex’s bottom line above the health an…

Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About * 100PercentFedUp.com * by Noah

The COVID-19 pandemic, and the ensuing response by the medical establishment, was an eye-opening experience for tens of millions of Americans. We watched as the medical establishment put the biopharmaceutical complex’s bottom line above the health and well-being of the American people. Sadly, greed in medicine isn’t new and it isn’t restricted just to pandemic responses. Indeed, greed is often the primary motivation for much of our medical estab…

Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About - Politics, Policy, Political Views

(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit. We appreciate your support!) The COVID-19 pandemic, and the ensuing response by the medical establishment, was an eye-opening experience for tens of millions of Americans. We watched as the

SAN FRANCISCO, U.S. and SUZHOU, China, April 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX: 01801), a world-class biopharmaceutical company dedicated to developing, manufacturing and commercializing innovative medicines for oncology, autoimmunity, metabolism, ophthalmology and other major disease areas, today announced that the National Medical Products Administration (NMPA) has approved the New Drug Application (NDA) for Aoyixin® (rie…

Innovent Biologics secures 2nd NDA approval for lung cancer drug as 1st-line treatment

Chinese regulators have approved a second new drug application filed by local pharmaceutical operator Innovent Biologics Inc (OTCMKTS: IVBXF).